Advanced Search
Contact | Corporate | Help

Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

Sponsors:
  • University of Oklahoma
  • Genentech
  • Sanofi-Aventis
  • M.D. Anderson Cancer Center
Phases:
  • Phase II
IndicationsAcronym:
  • Metastatic Pancreatic Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: bevacizumab
  • Drug: gemcitabine
  • Drug: oxaliplatin
Enrollment:
50

Additional information about NCT00222469.


SourceSolution © 2008-2012